- Home
- DLHC vs SRTS Comparison
DLHC vs SRTS Comparison
Compare DLHC & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- SRTS
- Stock Information
- Founded
- DLHC 1969
- SRTS 2010
- Country
- DLHC United States
- SRTS United States
- Employees
- DLHC N/A
- SRTS N/A
- Industry
- DLHC Business Services
- SRTS Medical/Dental Instruments
- Sector
- DLHC Consumer Discretionary
- SRTS Health Care
- Exchange
- DLHC Nasdaq
- SRTS Nasdaq
- Market Cap
- DLHC 112.9M
- SRTS 110.3M
- IPO Year
- DLHC N/A
- SRTS 2016
- Fundamental
- Price
- DLHC $7.37
- SRTS $8.48
- Analyst Decision
- DLHC
- SRTS Strong Buy
- Analyst Count
- DLHC 0
- SRTS 2
- Target Price
- DLHC N/A
- SRTS $12.50
- AVG Volume (30 Days)
- DLHC 27.1K
- SRTS 243.6K
- Earning Date
- DLHC 02-05-2025
- SRTS 02-05-2025
- Dividend Yield
- DLHC N/A
- SRTS N/A
- EPS Growth
- DLHC 410.00
- SRTS N/A
- EPS
- DLHC 0.51
- SRTS 0.57
- Revenue
- DLHC $395,937,000.00
- SRTS $41,308,000.00
- Revenue This Year
- DLHC N/A
- SRTS $65.04
- Revenue Next Year
- DLHC N/A
- SRTS $24.87
- P/E Ratio
- DLHC $14.43
- SRTS $14.83
- Revenue Growth
- DLHC 5.34
- SRTS 65.62
- 52 Week Low
- DLHC $7.34
- SRTS $2.91
- 52 Week High
- DLHC $17.58
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- DLHC 39.40
- SRTS 63.89
- Support Level
- DLHC $7.48
- SRTS $6.64
- Resistance Level
- DLHC $7.60
- SRTS $8.43
- Average True Range (ATR)
- DLHC 0.23
- SRTS 0.40
- MACD
- DLHC -0.04
- SRTS 0.17
- Stochastic Oscillator
- DLHC 3.30
- SRTS 84.24
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.